SummitTX Capital’s Lifestance Health LFST Stock Holding History

SummitTX Capital’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,451	Closed	-$59.2K	–	881
2025 Q2	$59.2K	Buy	+11,451	New	+$68.6K	﹤0.01%	720

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SummitTX Capital's LFST Position: Q3 2025 in Review

SummitTX Capital sold out of Lifestance Health (LFST) in Q3 2025, closing a stake of 11,451 shares — an estimated $59.2K sold.

SummitTX Capital first reported a position in LFST in Q2 2025 and held it in 1 quarter. The position peaked at $59.2K in Q2 2025. 210 funds tracked by Wall St. Rank hold LFST as of Q3 2025.

SummitTX Capital reported no remaining Lifestance Health position as of Q3 2025 after selling out during the quarter.
SummitTX Capital sold 11,451 Lifestance Health shares in Q3 2025, an estimated $59.2K.
SummitTX Capital first reported a position in Lifestance Health in Q2 2025 and held it in 1 quarter.
SummitTX Capital's Lifestance Health position peaked at $59.2K in Q2 2025.
210 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2025.

Based on SummitTX Capital's 13F filing for Q3 2025, filed 14 Nov 2025.